Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compliance in psychoses.

O Kampman1, K Lehtinen

  • 1Tampere University, Medical School, and Tampere University Hospital Department of Psychiatry, Finland.

Acta Psychiatrica Scandinavica
|September 24, 1999
PubMed
Summary

Medication side effects, patient attitudes, and insight significantly impact treatment adherence in psychoses. Understanding these factors is crucial for improving compliance in schizophrenia treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of obesity to reaction time and visual memory in schizophrenia.

Schizophrenia research. Cognition·2024
Same author

Association of somatic comorbidity and treatment adherence in patients with psychotic disorder.

Journal of psychiatric research·2024
Same author

Daily functioning and symptom factors contributing to attitudes toward antipsychotic treatment and treatment adherence in outpatients with schizophrenia spectrum disorders.

BMC psychiatry·2021
Same author

Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression.

Acta psychiatrica Scandinavica·2016
Same author

Association study of arcuate nucleus neuropeptide Y neuron receptor gene variation and serum NPY levels in clozapine treated patients with schizophrenia.

European psychiatry : the journal of the Association of European Psychiatrists·2016
Same author

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.

Translational psychiatry·2016

Area of Science:

  • Psychiatry
  • Pharmacology
  • Psychology

Background:

  • Treatment compliance is a critical factor in managing psychotic disorders, yet it remains a significant challenge.
  • Understanding the multifaceted nature of compliance is essential for developing effective therapeutic strategies in psychoses.

Purpose of the Study:

  • To conduct a comprehensive literature review on treatment compliance in patients with psychoses.
  • To evaluate the relative significance of various components influencing compliance in psychotic disorders.

Main Methods:

  • A systematic literature search was performed using Medline and PsycLit databases (1974-1997).
  • Keywords included 'schizophrenia' or 'psychosis' combined with 'compliance'.
  • Studies analyzing compliance as a distinct variable were selected for detailed examination.

Main Results:

  • Strong correlations with compliance were identified for medication side effects, patient attitudes, delusional symptoms, substance abuse, insight, and family support.
  • The impact of cognitive impairment on compliance was not definitively established.
  • Cognitive-behavioural and psychoeducational models demonstrate potential for enhancing therapeutic alliance and compliance.

Conclusions:

  • Medication-related factors are well-documented due to a focus on neuroleptic treatment.
  • Clinical compliance is influenced by patient-specific, medication-specific, and interactional factors (e.g., treatment model, therapeutic alliance).
  • Poor insight and cognitive deficits are key patient-related challenges in psychosis treatment compliance.

Related Experiment Videos